뉴스벤징가
Acadia Drug Misses Primary Goal in Alzheimer’s Related Psychosis
· 발표
기사 요약
Acadia Pharmaceuticals reports Phase 2 remlifanserin trial results for Alzheimer’s psychosis and plans to move into Phase 3.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Acadia Pharmaceuticals reports Phase 2 remlifanserin trial results for Alzheimer’s psychosis and plans to move into Phase 3.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…